Cancer Research and Treatment

A Novel Hematological Inflammation-Nutrition Score (HINS) and Its Related Nomogram Model to Predict Survival Outcome in Advanced Gastric Cancer Patients Receiving First-Line Palliative Chemotherapy

Journal of Inflammation Research.2023; Volume 16: 2929. CrossRef

Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort

Sylvain Manfredi, Marie Dior, Olivier Bouche, Emilie Barbier, Vincent Hautefeuille, Marielle Guillet, Justine Turpin, Vincent Bourgeois, Dall Osto Helene, Romain Desgrippes, Franck Audemar, Yann Molin, Christophe Locher, Thierry Chatellier, Thierry Lecomt

A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation

Guk Jin Lee, Hyunho Kim, Sung Shim Cho, Hyung Soon Park, Ho Jung An, In Sook Woo, Jae Ho Byun, Ji Hyung Hong, Yoon Ho Ko, Der Sheng Sun, Hye Sung Won, Jong Youl Jin, Ji Chan Park, In-Ho Kim, Sang Young Roh, Byoung Yong Shim

Journal of Gastric Cancer.2023; 23(2): 315. CrossRef

Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE‐063): A randomized, open‐label, phase 3 trial in Asian patients

Hyun Cheol Chung, Yoon‐Koo Kang, Zhendong Chen, Yuxian Bai, Wan Zamaniah Wan Ishak, Byoung Yong Shim, Young Lee Park, Dong‐Hoe Koo, Jianwei Lu, Jianming Xu, Hong Jae Chon, Li‐Yuan Bai, Shan Zeng, Ying Yuan, Yen‐Yang Chen, Kangsheng Gu, Wen Yan Zhong, Shu

Clinical Impact of Prognostic Nutrition Index for Advanced Gastric Cancer Patients with Peritoneal Metastases Treated Nivolumab Monotherapy

Jungmin Lee, Soo Ho Choi, Jin Ho Baek, Dong Won Baek, Jong Gwang Kim, Byung Woog Kang

A global perspective in second‐line treatment patterns for patients with advanced esophageal squamous cell carcinoma

Dena H. Jaffe, Joseph Gricar, Marc DeCongelio, deMauri S. Mackie

Current therapeutic options for gastric adenocarcinoma

C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad

Saudi Journal of Biological Sciences.2021; 28(9): 5371. CrossRef

A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care

K. Shimozaki, I. Nakayama, D. Takahari, D. Kamiimabeppu, H. Osumi, T. Wakatsuki, A. Ooki, M. Ogura, E. Shinozaki, K. Chin, K. Yamaguchi

Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)

Hye Sook Han, Bum Jun Kim, Hee-Jung Jee, Min-Hee Ryu, Se Hoon Park, Sun Young Rha, Jong Gwang Kim, Woo Kyun Bae, Keun-Wook Lee, Do-Youn Oh, In-Ho Kim, Sun Jin Sym, So Yeon Oh, Hyeong Su Kim, Ji-Hye Byun, Dong Sook Kim, Young Ju Suh, Hyonggin An, Dae Young

Therapeutic Advances in Medical Oncology.2021; 13: 175883592110428. CrossRef

Clinical management patterns of advanced and metastatic gastro‐oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom

Jacqueline Brown, Astra M. Liepa, Bela Bapat, Shweta Madhwani, Sylvie Lorenzen, Jesús García‐Foncillas, Sean D. Candrilli, James A. Kaye

European Journal of Cancer Care.2020;[Epub] CrossRef

Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer

David Gómez-Ulloa, Mayur Amonkar, Smita Kothari, Winson Y. Cheung, Ian Chau, John R. Zalcberg, Núria Lara Suriñach, Alfredo Falcone

Treatment Patterns Among Patients with Metastatic and/or Unresectable Gastric Cancer in Brazil

Fernando Meton de Alencar Camara Vieira, Ana Paula Ornellas de Souza Victorino, Daniel de Iracema Gomes Cubero, Carlos Augusto de Mendonça Beato, Eimy Minowa, Guilherme Silva Julian, Diego Novick

Journal of Gastrointestinal Cancer.2019; 50(4): 780. CrossRef

Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer

Jin Won Kim, Jong Gwang Kim, Byung Woog Kang, Ik-Joo Chung, Young Seon Hong, Tae-You Kim, Hong Suk Song, Kyung Hee Lee, Dae Young Zang, Yoon Ho Ko, Eun-Kee Song, Jin Ho Baek, Dong‐Hoe Koo, So Yeon Oh, Hana Cho, Keun-Wook Lee

Cancer Research and Treatment.2019; 51(1): 223. CrossRef

Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review study

Sergei A. Tjulandin, Alexey A. Tryakin, Natalia S. Besova, Evgeniya Sholokhova, Jasmina I. Ivanova, Wendy Y. Cheng, Luke M. Schmerold, Philippe Thompson-Leduc, Diego Novick

Journal of Drug Assessment.2019; 8(1): 150. CrossRef

Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL‑17

Resources and Costs Associated with the Treatment of Advanced and Metastatic Gastric Cancer in the Mexican Public Sector: A Patient Chart Review

Miguel Quintana, José A. Toriz, Diego Novick, Kyla Jones, Brenda S. Botello, Juan Alejandro Silva

PharmacoEconomics - Open.2018; 2(2): 191. CrossRef

Survival in Advanced Esophagogastric Adenocarcinoma Improves With Use of Multiple Lines of Therapy: Results From an Analysis of More Than 500 Patients

Michael Davidson, Catherine Cafferkey, Emily Frances Goode, Kyriakos Kouvelakis, Daniel Hughes, Pablo Reguera, Eleftheria Kalaitzaki, Clare Peckitt, Sheela Rao, David Watkins, Ian Chau, David Cunningham, Naureen Starling

Clinical Colorectal Cancer.2018; 17(3): 223. CrossRef